MirmosayyebOEbrahimiNBarzegarM, et al. Olfactory dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. PLoS ONE2022; 17(4): e0266492.
2.
BstehGHegenHBerekK, et al. Olfactory threshold predicts treatment response in relapsing multiple sclerosis. Mult Scler2022; 28(10): 1541–1552.
3.
RíoJNosCTintoréM, et al. Assessment of different treatment failure criteria in a cohort of relapsing-remitting multiple sclerosis patients treated with interferon beta: Implications for clinical trials. Ann Neurol2002; 52(4): 400–406.
4.
BstehGHegenHLadstätterF, et al. Change of olfactory function as a marker of inflammatory activity and disability progression in MS. Mult Scler2019; 25(2): 267–274.
